Lupin receives FDA approval for seizures medication Diazepam Rectal Gel
Lupin announced that its subsidiary Novel Laboratories has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application for ... Read More
Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India
Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More
Lupin gets Health Canada approval for generic Spiriva for COPD treatment
Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to market a generic version of Spiriva (tiotropium ... Read More
Lupin launches satellite laboratory in Vijayawada to expand diagnostics network
Indian healthcare company Lupin has announced the establishment of a satellite laboratory in Vijayawada, Andhra Pradesh, as part of its ongoing expansion in the diagnostics ... Read More
Lupin to acquire French generics injectables developer Medisol
Indian pharma company Lupin has agreed to acquire Medisol, a French pharmaceutical company, for an undisclosed price. Established in 2011, Medisol is engaged in developing ... Read More
Lupin expands diagnostics network with Bengaluru regional reference lab
Lupin Diagnostics, a subsidiary of Indian pharma company Lupin, has opened its new regional reference laboratory in Bengaluru as part of the growth of its ... Read More
Lupin bags tentative approval for Ocaliva Tablets generic in US
Lupin said that it has been issued tentative approval for Obeticholic Acid Tablets, 5 mg and 10 mg from the US Food and Drug Administration ... Read More
Lupin partner Caplin Steriles gets FDA nod for Zemuron Bromide generic
Lupin Limited said that its alliance partner Caplin Steriles has won final approval for Rocuronium Bromide Injection, 10mg/mL in 5 mL and 10 mL multi-dose ... Read More
FDA concludes inspection at Lupin Bioresearch Centre in Pune
Lupin said that the US Food and Drug Administration (FDA) has concluded an inspection of the company’s bioresearch centre in Pune, Maharashtra. The inspection was ... Read More
Lupin reports completion of FDA inspection at Vizag plant with no observations
Lupin said that the US Food and Drug Administration (FDA) has wrapped up a pre-approval and GMP inspection of its API manufacturing plant in Visakhapatnam, ... Read More